Download Files:
Givinostat
$90 – $560
Products Details
Product Description
– Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.
Web ID
– HY-14842
Storage Temperature
– -20°C, 3 years (Powder)
Shipping
– Blue Ice
Applications
– Cancer-programmed cell death
Molecular Formula
– C24H27N3O4
Citations
– Acta Pharmacol Sin. 2021 Apr 13.|Cell Prolif. 2021 May 24;e13072.|Commun Biol. 2021 Oct 29;4(1):1235.|J Orthop Transl. 29 (2021) 106-112.|Neuroscience. 2021 Apr 13;S0306-4522(21)00185-8.|Cell Death Dis. 2020 Sep 15;11(9):753.|J Mol Med (Berl). 2019 Aug;97(8):1183-1193.
References
– [1]Leoni F, et al. The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med. 2005 Jan-Dec;11(1-12):1-15.|[2]Li S, et al. Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo. J Biol Chem. 2015 Jan 23;290(4):2368-78.|[3]Wang YG, et al. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol. 2015 Jul 21;21(27):8326-39.
CAS Number
– 497833-27-9
Molecular Weight
– 421.49
Compound Purity
– 98.05
SMILES
– O=C(OCC1=CC=C2C=C(CN(CC)CC)C=CC2=C1)NC3=CC=C(C(NO)=O)C=C3
Clinical Information
– Phase 3
Research Area
– Cancer
Solubility
– DMSO : 250 mg/mL (ultrasonic)
Target
– HDAC
Isoform
– HD1;HD2;HDAC1;HDAC10;HDAC11;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9
Pathway
– Cell Cycle/DNA Damage;Epigenetics
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
